Eculizumab, a humanized anti-C5 mAb, which is applied for paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremia syndrome and neuromyelitis optica spectrum disorder, was used for four severe COVID-19 cases. The gene discussed is C5; the disease is COVID-19.